Literature DB >> 19788393

Clearance and control mechanisms of hemoglobin from cradle to grave.

Dominik J Schaer, Abdu I Alayash.   

Abstract

Hemoglobin is a highly reactive molecule, and besides its oxygen-carrying capacity, it has multiple enzymatic and ligand-binding activities that have only recently been explored as fundamental pathophysiologic mechanisms. Nitric oxide neutralization, generation of potentially toxic radical species, and heme-mediated inflammation are among the most extensively studied mechanisms of Hb-mediated pathology. Extracellular Hb has an established role in sickle cell disease and other hemolytic disorders. However, extracellular Hb seems also to have relevant disease-modifying activities in many other important pathologic conditions, such as malaria and atherosclerosis. In this Forum, we summarize the current knowledge of mechanisms of Hb toxicity. Special emphasis is given to the highly efficient endogenous scavenger and detoxification pathways, such as alpha-hemoglobin stabilizing protein (AHSP), haptoglobin, hemopexin, CD163, and heme oxygenase. Systemic and local activity of these pathways finally determines the impact of extracellular Hb on physiology and tissue homeostasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19788393     DOI: 10.1089/ars.2009.2923

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  26 in total

Review 1.  Cell-free hemoglobin and its scavenger proteins: new disease models leading the way to targeted therapies.

Authors:  Dominik J Schaer; Paul W Buehler
Journal:  Cold Spring Harb Perspect Med       Date:  2013-06-01       Impact factor: 6.915

2.  Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease.

Authors:  Stéphane M Camus; João A De Moraes; Philippe Bonnin; Paul Abbyad; Sylvain Le Jeune; François Lionnet; Laurent Loufrani; Linda Grimaud; Jean-Christophe Lambry; Dominique Charue; Laurent Kiger; Jean-Marie Renard; Claire Larroque; Hervé Le Clésiau; Alain Tedgui; Patrick Bruneval; Christina Barja-Fidalgo; Antigoni Alexandrou; Pierre-Louis Tharaux; Chantal M Boulanger; Olivier P Blanc-Brude
Journal:  Blood       Date:  2015-03-31       Impact factor: 22.113

3.  Inheritance of the Bantu/Benin haplotype causes less severe hemolytic and oxidative stress in sickle cell anemia patients treated with hydroxycarbamide.

Authors:  Jéssika V Okumura; Danilo G H Silva; Lidiane S Torres; Edis Belini-Junior; Willian M Barberino; Renan G Oliveira; Gisele C S Carrocini; Gabriela B Gelaleti; Clarisse L C Lobo; Claudia R Bonini-Domingos
Journal:  J Hum Genet       Date:  2016-03-10       Impact factor: 3.172

Review 4.  Development of recombinant hemoglobin-based oxygen carriers.

Authors:  Cornelius L Varnado; Todd L Mollan; Ivan Birukou; Bryan J Z Smith; Douglas P Henderson; John S Olson
Journal:  Antioxid Redox Signal       Date:  2012-11-16       Impact factor: 8.401

5.  Hemoglobin Kirklareli (α H58L), a New Variant Associated with Iron Deficiency and Increased CO Binding.

Authors:  Emmanuel Bissé; Christine Schaeffer-Reiss; Alain Van Dorsselaer; Tchilabalo Dilezitoko Alayi; Thomas Epting; Karl Winkler; Andres S Benitez Cardenas; Jayashree Soman; Ivan Birukou; Premila P Samuel; John S Olson
Journal:  J Biol Chem       Date:  2016-12-23       Impact factor: 5.157

6.  Emergence of the acute-phase protein hemopexin in jawed vertebrates.

Authors:  Helen Dooley; E Bryan Buckingham; Michael F Criscitiello; Martin F Flajnik
Journal:  Mol Immunol       Date:  2010-09-29       Impact factor: 4.407

7.  Hemoglobin α and β are ubiquitous in the human lung, decline in idiopathic pulmonary fibrosis but not in COPD.

Authors:  Nobuhisa Ishikawa; Steffen Ohlmeier; Kaisa Salmenkivi; Marjukka Myllärniemi; Irfan Rahman; Witold Mazur; Vuokko L Kinnula
Journal:  Respir Res       Date:  2010-09-13

8.  In vivo reduction of cell-free methemoglobin to oxyhemoglobin results in vasoconstriction in canines.

Authors:  Dong Wang; Barbora Piknova; Steven B Solomon; Irene Cortes-Puch; Steven J Kern; Junfeng Sun; Tamir Kanias; Mark T Gladwin; Christine Helms; Daniel B Kim-Shapiro; Alan N Schechter; Charles Natanson
Journal:  Transfusion       Date:  2013-03-14       Impact factor: 3.157

9.  Oxidized Ferric and Ferryl Forms of Hemoglobin Trigger Mitochondrial Dysfunction and Injury in Alveolar Type I Cells.

Authors:  Narendranath Reddy Chintagari; Sirsendu Jana; Abdu I Alayash
Journal:  Am J Respir Cell Mol Biol       Date:  2016-08       Impact factor: 6.914

10.  Hepatic Overexpression of Hemopexin Inhibits Inflammation and Vascular Stasis in Murine Models of Sickle Cell Disease.

Authors:  Gregory M Vercellotti; Ping Zhang; Julia Nguyen; Fuad Abdulla; Chunsheng Chen; Phong Nguyen; Carlos Nowotny; Clifford J Steer; Ann Smith; John D Belcher
Journal:  Mol Med       Date:  2016-07-19       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.